New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2014
08:08 EDTIDIXIdenix appoints Jacques Dumas, Ph.D., as Chief Scientific Officer
Idenix Pharmaceuticals announced that it has appointed Jacques Dumas, Ph.D., as its executive vice president and Chief Scientific Officer. Dr. Dumas is trained as a medicinal chemist and brings over 20 years of experience in pharmaceutical discovery and development, supporting a variety of programs in infectious diseases and oncology. He is a co-inventor of two marketed drugs in the field of oncology, Nexavar and Stivarga. His appointment will be effective January 20, 2014.
News For IDIX From The Last 14 Days
Check below for free stories on IDIX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 17, 2014
11:12 EDTIDIXOptions with decreasing implied volatility
Subscribe for More Information
July 14, 2014
10:00 EDTIDIXOptions with decreasing implied volatility: SHPG INFY CWH FDO IDIX FAST

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use